Previous Page  6 / 28 Next Page
Information
Show Menu
Previous Page 6 / 28 Next Page
Page Background

Page 48

Notes:

allied

academies

Cell Science, Stem Cell Research &

Pharmacological Regenerative Medicine

November 29-30, 2017 | Atlanta, USA

Annual Congress on

Adv cel sci tissue cul 2017 | Volume 1 Issue 2

A study on effect of anti-tuberculosis drugs on liver function

Liliane Uwimana

University of Rwanda, Rwanda

A

study is aimed to assess the effect of anti-tuberculosis

drugs on liver function among the patients who

attended King Faisal Hospital during the period of two years.

A sample of 165 tuberculosis patients receiving the standard

treatment of TB drug during the period of two years was

done, only 22 patients for whom liver function test was

done before and during treatment with anti-tuberculosis

(TB) drugs were considered. The hepatotoxicity consisted

of high concentration of ALT (Alanine Amino Transferase)/

AST (Aspartate Amino Transferase), Jaundice or high

concentration of total bilirubin. The result revealed that

among 22 patients, 68.5% had ALT/AST at normal range at the

beginning of treatment with anti TB drugs. After 3 months of

anti TB therapy the record showed that 45% of them has ALT

beyond the normal range and after 6 months of therapy the

ALT level showed high frequency of liver dysfunction up to

79%. It is essential to monitor liver function from beginning

of therapy with anti-tuberculosis drugs.

Speaker Biography

Liliane Uwimana is working as a Pharmacist in Pharmacie Royale and has completed

her Bachelor’s degree from University of Rwanda. She has worked in King Faisal

Hospital as Pharmacist where she did her research on Effect of Anti Tuberculosis Drugs

on Liver Function.

e:

lilianeuwimana58@gmail.com